WHC is still in active development. Read this to understand our approach.
depiction of OZYUPQUCAUTOBP-UHFFFAOYSA-N.svg
isomerdesign

Levallorphan

Verificar en isomerdesign

pubchem

Levallorphan

Verificar en pubchem

drugmap

Levallorphan

Verificar en drugmap

wiki

Levallorphan

Verificar en wiki

wiki

Dextrallorphan

Verificar en wiki

Data

InChI: InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2

Sinónimos: Morphinan-3-ol, 17-allyl-, (-)-,353613BU4U,Levallorphanum [INN-Latin],Tox21_112005,CAS-152-02-3, L-N-Allyl-3-hydroxymorphinan,DSSTox_GSID_23205,Ro-1-7700,HSDB 2148,(-)-3-Hydroxy-N-allylmorphinan, Levallorphanum,Levallorphane,NCGC00162247-02,LEVALLORPHAN [MI], Levalorfano, (-)-3-Hydroxy-N-allylmorphinan,LEVALLORPHAN [HSDB],CHEMBL1254682,ZINC3875992,(-)-17-allylmorphinan-3-ol,BDBM50326673,(a^?-17-allylmorphinan-3-ol,Levo-3-hydroxy-N-allyl morphinan,152-02-3, Levallorphanum [INN-Latin], 17-prop-2-en-1-ylmorphinan-3-ol, Naloxiphan,Q6534827, Levallorphan [INN:BAN],levallorphan, Ro-1-7700,Levalorfano,EN300-19767758,Levallorphane [INN-French],17-prop-2-en-1-ylmorphinan-3-ol,LEVALLORPHAN [INN],Lorfan,(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-4-ol,17-allyl-(1R,9R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol( Levallorphan),EINECS 205-799-1,C07069,Levallofano,Levallofano [DCIT],(1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol,Tox21_112005_1,Morphinan, 17-allyl-3-hydroxy-,UNII-353613BU4U, N-Allyl-3-hydroxymorphinan,Levallorphanum,DSSTox_CID_3205, 17-Allylmorphinan-3-ol,(levallorphan)17-allyl-(1R,9R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol,DB00504, Levallorphane [INN-French],Levallorphan [INN:BAN],LEVALLORPHAN [WHO-DD],N-Allyl-3-hydroxymorphinan,SCHEMBL34060,17-Allylmorphinan-3-ol,CHEBI:6431,Morphinan-3-ol, 17-allyl-,NCGC00162247-06,Levalorfano [INN-Spanish],Levallorphan, Lorfan (TN),L-N-Allyl-3-hydroxymorphinan, Levo-3-hydroxy-N-allyl morphinan, Levallofano [DCIT],Naloxiphan, Levalorfano [INN-Spanish],DTXSID9023205,GTPL7209,17-allyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (Levallorphan),DSSTox_RID_76925, Levallorphane

Estimated data

Solubilidad: -3.685 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 97.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.